Genetic Networks is classified as operating in the Research & Development in the Physical, Engineering & Life Sciences industry, NAICS Code 54171.
Trademark Applications
Trademark applications show the products and services that Genetic Networks is developing and marketing.
Genetic Networks doesn't have any recent trademark applications, indicating Genetic Networks is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
DO THE RIGHT THING... RIGHT! Drug discovery services; scientific and technological services, namely, scientific research and analysis in the field target and drug optimization; scientific research screening of pharmaceuticals and biologics for therapeutic use including small molecules, proteins, RNA and DNA; scientific research screening using an entire genomes response to an administered compound or compounds; scientific research screening to find responses to therapeutic compounds by gene variants in a patient population; scientific research screening to find adverse events to therapeutic compounds and functional gene cluster mapping of interacting genes of an entire genomic response to administered compound; scientific research for medical purposes for identification of new clinical indications for known compounds; scientific research for medical purposes for comprehensive disease space mapping to understand how a compound fits into a disease space; and scientific research and comprehensive analysis of competitive drugs and derivatives thereof from a functional genome response to find new drug targets
04/29/2020
GENESCAPE Drug discovery services; scientific and technological services, namely scientific research and analysis in the field of target and drug optimization; scientific research screening of pharmaceuticals and biologics for therapeutic use including small molecules, proteins, RNA and DNA; scientific research screening using an entire genomes response to an administered compound or compounds; scientific research screening to find responses to therapeutic compounds by gene variants in a patient population; scientific research screening to find adverse events to therapeutic compounds and functional gene cluster mapping of interacting genes of an entire genomic response to administered compound; scientific research for medical purposes for identification of new clinical indications for known compounds; scientific research for medical purposes for comprehensive disease space mapping to understand how a compound fits into a disease space; and scientific research and comprehensive analysis of competitive drugs and derivatives thereof from a functional genome response to find new drug targets
11/19/2019
See all trademarks and details in the Full Report.
Market Share of Genetic Networks's Largest Competitors
A competitive analysis shows these companies are in the same general field as Genetic Networks, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Genetic Networks.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Genetic Networks and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.